Cargando…

Patient-Centered Obstetric Care in the Age of Cell-Free Fetal DNA Prenatal Screening

PURPOSE: The clinical introduction of innovative prenatal genetic technologies challenges patients and providers to find new ways of fostering informed decision-making in a setting characterized by complexity and uncertainty. As prenatal genetic technology advances, important questions remain about...

Descripción completa

Detalles Bibliográficos
Autores principales:	Agatisa, Patricia K, Mercer, Mary Beth, Mitchum, Ariane, Coleridge, Marissa B, Farrell, Ruth M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862378/ https://www.ncbi.nlm.nih.gov/pubmed/29582008 http://dx.doi.org/10.1177/2374373517720482

Ejemplares similares

Online direct-to-consumer messages about non-invasive prenatal genetic testing
por: Farrell, Ruth M., et al.
Publicado: (2016)

It’s More Than a Blood Test: Patients’ Perspectives on Noninvasive Prenatal Testing
por: Farrell, Ruth M., et al.
Publicado: (2014)

Decision-making for prenatal genetic screening: how will pregnant women navigate a growing number of aneuploidy and carrier screening options?
por: Farrell, Ruth M., et al.
Publicado: (2021)

Overall evaluation of the clinical value of prenatal screening for fetal-free DNA in maternal blood
por: Yu, Bin, et al.
Publicado: (2017)

Application of fetal cell-free DNA enrichment in non-invasive prenatal screening: experience from a single center in Eastern China
por: Lin, Ying, et al.
Publicado: (2021)

Cell-free fetal DNA testing and its correlation with prenatal indications
por: Wang, Jing-wei, et al.
Publicado: (2021)

The Impact of Outpatient Prenatal Care Visitor Restrictions on Pregnant Patients and Partners During the COVID-19 Pandemic
por: Collart, Christina, et al.
Publicado: (2022)

Prenatal screening for fetal aneuploidies with cell-free DNA in the general pregnancy population: a cost-effectiveness analysis
por: Fairbrother, Genevieve, et al.
Publicado: (2016)

Cell‐free DNA fetal fraction in twin gestations in single‐nucleotide polymorphism‐based noninvasive prenatal screening
por: Hedriana, Herman, et al.
Publicado: (2019)

Performance of a universal prenatal screening program incorporating cell-free fetal DNA analysis in Ontario, Canada
por: Dougan, Shelley D., et al.
Publicado: (2021)

Implementing Prenatal Diagnosis Based on Cell-Free Fetal DNA: Accurate Identification of Factors Affecting Fetal DNA Yield
por: Barrett, Angela N., et al.
Publicado: (2011)

Noninvasive Prenatal Diagnosis of Fetal RHD Status Using Cell-free Fetal DNA in Maternal Plasma
por: Ahmadi, Mohammad Hossein, et al.
Publicado: (2022)

Impact of Cell-Free Fetal DNA Screening on Patients’ Choice of Invasive Procedures after a Positive California Prenatal Screen Result
por: Shah, Forum T., et al.
Publicado: (2014)

Correction to “Performance of a universal prenatal screening program incorporating cell-free fetal DNA analysis in Ontario, Canada”
Publicado: (2021)

Cell-Free Fetal Deoxyribonucleic Acid (cffDNA) Analysis as a Remarkable Method of Non-Invasive Prenatal Screening
por: Raj, Himanshu, et al.
Publicado: (2022)

The Successes and Challenges of Implementing Telehealth for Diverse Patient Populations Requiring Prenatal Care During COVID-19: Qualitative Study
por: Farrell, Ruth, et al.
Publicado: (2022)

Non-invasive prenatal diagnosis of fetal trisomy 21 using cell-free fetal DNA in maternal blood
por: Lim, Ji Hyae, et al.
Publicado: (2013)

Impact of Telehealth on the Delivery of Prenatal Care During the COVID-19 Pandemic: Mixed Methods Study of the Barriers and Opportunities to Improve Health Care Communication in Discussions About Pregnancy and Prenatal Genetic Testing
por: Craighead, Caitlin G, et al.
Publicado: (2022)

Safe, accurate, prenatal diagnosis of thanatophoric dysplasia using ultrasound and free fetal DNA
por: Chitty, Lyn S, et al.
Publicado: (2013)

Performance of non-invasive prenatal testing when fetal cell-free DNA is absent
por: Takoudes, T, et al.
Publicado: (2015)

Fetal fraction‐based risk algorithm for non‐invasive prenatal testing: screening for trisomies 13 and 18 and triploidy in women with low cell‐free fetal DNA
por: McKanna, T., et al.
Publicado: (2018)

Genetic deconvolution of fetal and maternal cell-free DNA in maternal plasma enables next-generation non-invasive prenatal screening
por: Xu, Chenming, et al.
Publicado: (2022)

Targeted fetal cell‐free DNA screening for aneuploidies in 4,594 pregnancies: Single center study
por: Koc, Altug, et al.
Publicado: (2019)

Factors affecting cell-free DNA fetal fraction: statistical analysis of 13,661 maternal plasmas for non-invasive prenatal screening
por: Hou, Yaping, et al.
Publicado: (2019)

Hemolysis and Fetal Fraction in Cell-Free DNA Blood Collection Tubes for Noninvasive Prenatal Testing
por: Stokowski, Renee, et al.
Publicado: (2020)

Economic evaluation of prenatal screening for fetal aneuploidies in Thailand
por: Wongkrajang, Preechaya, et al.
Publicado: (2023)

Positive predictive value of non-invasive prenatal screening for fetal chromosome disorders using cell-free DNA in maternal serum: independent clinical experience of a tertiary referral center
por: Neufeld-Kaiser, Whitney A., et al.
Publicado: (2015)

Evaluation of prenatal central nervous system anomalies: obstetric management, fetal outcomes and chromosome abnormalities
por: Tan, Ann Gee, et al.
Publicado: (2022)

Virtual prenatal visits associated with high measures of patient experience and satisfaction among average-risk patients: a prospective cohort study
por: Bruno, Bethany, et al.
Publicado: (2023)

Low Fetal Fraction of Cell Free DNA at Non-Invasive Prenatal Screening Increases the Subsequent Risk of Preterm Birth in Uncomplicated Singleton Pregnancy
por: Yuan, Xiaosong, et al.
Publicado: (2022)

Analysis of cell‐free fetal DNA for non‐invasive prenatal diagnosis in a family with neonatal diabetes
por: De Franco, E., et al.
Publicado: (2016)

The current applications of cell-free fetal DNA in prenatal diagnosis of single-gene diseases: A review
por: Mahdi Mortazavipour, Mohamad, et al.
Publicado: (2022)

Prenatal Diagnosis of Fetal Encephalomalacia after Maternal Diabetic Ketoacidosis
por: Love, Rozalyn, et al.
Publicado: (2014)

Fetal Right Ventricular Diverticulum Detected by Prenatal Ultrasound Screening
por: Katsura, Daisuke, et al.
Publicado: (2016)

Prenatal cell‐free DNA screening for fetal aneuploidy in pregnant women at average or high risk: Results from a large US clinical laboratory
por: Guy, Carrie, et al.
Publicado: (2019)

We Need to Improve Prenatal Screening Practices in Primary Obstetric Care: A Representative Data from a Fetal Medicine Unit in Coastal Karnataka
por: Poojari, Vidyashree Ganesh, et al.
Publicado: (2021)

Prenatal screening of fetal ventriculoarterial connections: benefits of 4D technique in fetal heart imaging
por: Wang, Yu, et al.
Publicado: (2017)

The clinical utility of DNA-based screening for fetal aneuploidy by primary obstetrical care providers in the general pregnancy population
por: Palomaki, Glenn E., et al.
Publicado: (2017)

High Levels of Sample-to-Sample Variation Confound Data Analysis for Non-Invasive Prenatal Screening of Fetal Microdeletions
por: Chu, Tianjiao, et al.
Publicado: (2016)

Prenatal Prediction of Outcome by Fetal Gastroschisis in a Tertiary Referral Center
por: Nitzsche, Katharina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ft3fadb4ielnf21g94kbldq8p2